Jeong-Han Park

Title: Jeong-Han Park: Innovator in Pharmaceutical Compounds

Introduction

Jeong-Han Park is a notable inventor based in Flanders, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target diseases of the central nervous system. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Jeong-Han Park holds a patent for O-carbamoyl-phenylalaninol compounds, which are pharmaceutically useful. This invention relates to a racemic or enantiomerically enriched O-carbamoyl-phenylalaninol compound, represented by a specific structural formula. The patent outlines the potential of these compounds and their pharmaceutically acceptable salts to treat various central nervous system diseases.

Career Highlights

Throughout his career, Jeong-Han Park has demonstrated a strong commitment to research and innovation. He is currently associated with Yukong Limited, where he continues to explore new pharmaceutical solutions. His work has not only contributed to the scientific community but has also paved the way for future advancements in drug development.

Collaborations

Jeong-Han Park has collaborated with esteemed colleagues, including Yong Moon Choi and Dong Il Han. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research.

Conclusion

Jeong-Han Park is a distinguished inventor whose work in pharmaceutical compounds has the potential to make a significant impact on the treatment of central nervous system diseases. His dedication to innovation and collaboration exemplifies the spirit of advancement in the field of medicine.